Clinical trials: Contrast Agent
Cardiovascular Diseases, Microvascular Complications
Non-invasive Microvascular Assessment in Individuals at High Risk of Cardiovascular Disease From the SCAPIS2 Study
Microvascular dysfunction, particularly endothelial dysfunction, is increasingly recognized as a key mechanism underlying various cardiovascular diseases (CVD), including heart failure, ischemic heart disease, atherosclerosis…
- Trial name
- NCT07359768
- Where
- Sweden
- Volunteers
- 900 people
- Sponsor
- HJN Sverige AB/Neko Health
Intensive Care Unit, Acute Kidney Injury
The Diagnostic Value of Contrast-enhanced Ultrasound in Acute Kidney Injury in ICU
The goal of this observational study is to quantitatively assess the renal microcirculation changes by contrast-enhanced ultrasound (CEUS) and to obtain systemic hemodynamic information by ultrasound Doppler at the same time, to…
- Conditions
- Intensive Care Unit, Acute Kidney Injury, Ultrasound
- Trial name
- NCT06353659
- Testing
- Contrast-enhanced Ultrasound
- Volunteers
- 60 people
- Sponsor
- Peking University Third Hospital
Osteoarthritis, Obesity
Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
This is a substudy to a randomised trial investigating the effect of liraglutide on body weight and pain in overweight or obese patients with knee osteoarthritis (NCT02905864).
- Trial name
- IM-LOSEIT-II (NCT02928679)
- Testing
- Liraglutide 3 mg (Saxenda)
- Where
- Denmark
- Volunteers
- 150 people
- Sponsor
- Henrik Gudbergsen
Head and Neck Cancer
Dynamic Contrast Enhanced Computed Tomography (CT) for Head and Neck Cancer
For patients undergoing treatment for head and neck cancer, this study will use dynamic contrast-enhanced CT scans to try to determine which lymph nodes in the neck contain cancer and require surgical removal.
- Trial name
- NCT01549379
- Testing
- Dynamic Contrast Enhanced CT scan
- Where
- Canada
- Volunteers
- 1 people
- Sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Breast Cancer, Breast Neoplasms
Contrast-Enhanced Stereotactic Biopsy
Contrast-enhanced mammography (CEM) is an emerging breast imaging modality that is based on dual-energy mammography and the injection of iodinated contrast agent.
- Conditions
- Breast Cancer, Breast Neoplasms, Breast Cancer Female
- Trial name
- CESB (NCT06062992)
- Testing
- Contrast Enhanced Stereotactic Biopsy
- Where
- Netherlands
- Volunteers
- 77 people, healthy volunteers welcome
- Sponsor
- Zuyderland Medisch Centrum
Breast Cancer
Onco4D(TM) Biodynamic Chemotherapy Selection for Breast Cancer Patients
Millions of cancer patients every year receive chemotherapy with only a 20-60% probability of pathological response, while most experience adverse side effects that lower quality of life without prolonging it.
- Trial name
- NCT03164863
- Testing
- Onco4D Biodynamic Chemotherapy Selection Assay
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- Animated Dynamics, Inc.
Kidney Injury, Acute, Perfusion Imaging
Validation of Renal Perfusion CEUS Against MRI, and Its Application in Acute Kidney Injury
The purposes of this study is 1. To establish the validity of CEUS to measure renal perfusion by comparing it against ASL-MRI in young and older healthy volunteers, and generate a normative dataset of CEUS measures of renal…
- Conditions
- Kidney Injury, Acute, Perfusion Imaging, Ultrasonography, Kidney Diseases
- Trial name
- NCT04181281
- Testing
- Contrast enhanced ultrasound, Arterial Spin Labelling -Magnetic Resonance Imaging
- Where
- United Kingdom
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- University of Nottingham
Adverse Reaction to Drug, Allergic Reaction to Contrast Media
Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age
Our primary outcome is to assess the safety of Dotarem in children <2 years old up to 24 hours after Dotarem injection. Patients will be monitored for any adverse events that occur for 2 hours following the completion of the MRI…
- Trial name
- NCT02609919
- Testing
- Gadoteric Acid
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- St. Louis University
Cerebral Hemorrhage, Acute Lobar Haematoma
Descriptive Study on MRI Contrast of Acute Cerebral Hemorrhage in Different Microangiopathies
Cerebral haemorrhage represents a minority of acute vascular syndromes (less frequent than ischemic stroke, at around 20%), but with a therapeutic impasse, having no specific treatment.
- Trial name
- GADO-ICH (NCT06781034)
- Testing
- None, pure observational study
- Where
- France
- Volunteers
- 128 people
- Sponsor
- Centre Hospitalier Universitaire de Nīmes
Prostate Cancer
Gadopiclenol in Contrast Enhanced MRI of the Prostate
The fundamental aim of this study is to show that the novel contrast agent Gadopiclenol (Elucirem), with its high relaxivity, facilitates increased contrast enhancement and improved differentiation of clinically significant…
- Trial name
- NCT06226129
- Testing
- Gadopiclenol
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- Columbia University
Pancreatic Cancer, Ultrasonography
Radiographic Response to Chemotherapy in Unresected Localized Pancreatic Cancer
The goal of this observational study is to explore whether contrast-enhanced ultrasound (CEUS) can early predict and evaluate the treatment response of first-line chemotherapy in locally advanced and borderline resectable…
- Conditions
- Pancreatic Cancer, Ultrasonography, First-line Chemotherapy
- Trial name
- NCT05729737
- Testing
- Contrast-enhanced ultrasound(CEUS)
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Peking Union Medical College Hospital
Breast Neoplasms
Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer
This study will examine a non-invasive method to assess vasculature, that is, the development of a blood supply necessary to the growth of tumors.
- Trial name
- NCT00071357
- Where
- United States
- Volunteers
- 78 people
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
Contrast-induced Nephropathy
Predictive Value of CHA2DS2-VASC Score and Contrast Volume to Creatinine Clearance Ratio in Relation to Mehran Score for Contrast-Induced Nephropathy In ST- Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
all patient presented with ST elevated myocardial infarction and underwent PPCI will be calculated with CHA2DS2-VASC score and contrast volume / creatinine clearance as apredictive value for Contrast induced nephropathy and the…
- Trial name
- NCT03266458
- Testing
- Primary percutaneous coronary intervention
- Where
- Egypt
- Volunteers
- 210 people
- Sponsor
- Assiut University
Breast Cancer Female, Breast Cancer
Tomosynthesis vs. Contrast-Enhanced Mammography in Women With Personal History of Breast Cancer in Western Pennsylvania
This is a prospective clinical trial that will examine if contrast-enhanced mammography substantially improves breast cancer detection compared to mammography with tomosynthesis, with minimal increase in false-positives, in women…
- Conditions
- Breast Cancer Female, Breast Cancer, Breast Neoplasms, Neoplasms
- Trial name
- TOCEM (NCT04085510)
- Testing
- Contrast-enhanced mammogram
- Where
- 3 sites in United States
- Volunteers
- 1,647 people, healthy volunteers welcome
- Sponsor
- Wendie Berg
Urolithiasis, Ureterolithiasis
PRedictive Accuracy of Initial Stone Burden Evaluation.
This study is intended to be a prospective registry of patients undergoing any kind of stone treatment that have a pre-operative CT available.
- Conditions
- Urolithiasis, Ureterolithiasis, Nephrolithiasis
- Trial name
- PRAISE (NCT04746378)
- Testing
- Computed Tomography, CSD, Computed Tomography, SA, Computed Tomography, 3D
- Where
- Belgium
- Volunteers
- 1,000 people
- Sponsor
- University Hospital, Ghent
End Stage Kidney Disease, Fibrosis Myocardial
Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
There are currently no good ways of measuring levels of scarring in the hearts of patients with advanced kidney disease and patients on dialysis, although recent research has shown a new cardiac MRI technique, called native T1…
- Trial name
- CONFIRM (NCT03586518)
- Testing
- Cardiac MRI scan, Echocardiogram, Cardiac explantation
- Where
- United Kingdom
- Volunteers
- 9 people
- Sponsor
- University of Leicester
Acute Kidney Injury
Preconditioning Against Renal Damage Under Contrast Examination
This study aims to assess if applying an ischaemic insult to an arm before giving intravenous contrast will help decrease the incidence of developing contrast induced acute renal injury in patients undergoing contrast-enhanced CT…
- Trial name
- Re-DUCE-F (NCT02054858)
- Testing
- RIPC
- Where
- Ireland
- Volunteers
- 1,000 people
- Sponsor
- Mid Western Regional Hospital, Ireland
Ophthalmoplegia
Prevalence of Contrast Enhancement of the Oculomotor Nerve on 3D PD T1 MRI Sequence in Patients With Ophthalmoplegia
Oculomotor nerve (third cranial nerve or "III") palsy is a relatively frequent cause of consultation in ophthalmology. It may reveal a life-threatening pathology such as aneurysm rupture, pituitary apoplexy, and therefore need…
- Trial name
- 3D-III (NCT03269682)
- Testing
- 3D PD T1 MRI sequence
- Where
- France
- Volunteers
- 134 people
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
Transcatheter Aortic Valve Replacement
CT TAVR Abdomen Study
A standard polyenergetic CT (computed tomography) procedure utilizes 100 ml of iodinated contrast. A recent world-wide shortage of iodine based intravenous contrast has highlighted the need to search for alternative methods or…
- Trial name
- CT TAVR (NCT05758701)
- Testing
- Iodinated Contrast Agent (Omnipaque), Dual Energy CT
- Where
- United States
- Volunteers
- 164 people, healthy volunteers welcome
- Sponsor
- University of Maryland, Baltimore
Kidney Cancer
Open-label Pilot Evaluating Renal Lesions w/ Contrast-enhaced US in Patients w/ Renal Cancer
This prospective pilot study is designed to evaluate the accuracy of contrast-enhanced ultrasound when used to evaluate renal lesions in two different populations; patients with known renal tumors (Cohort 1) and patients with a…
- Trial name
- NCT01751529
- Testing
- Contrast-enhanced Ultrasound, Perflutren lipid
- Where
- United States
- Volunteers
- 48 people
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.